TORONTO — Moderna says Health Canada has approved its mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older. The company says it expects the RSV vaccine — called mRESVIA — to be available in early 2025.
TORONTO — Moderna says Health Canada has approved its mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older.
The company says it expects the RSV vaccine — called mRESVIA — to be available in early 2025. There are two other vaccines already available in Canada to protect seniors against severe illness caused by RSV: Arexvy, manufactured by GSK, and Abrysvo, made by Pfizer. Earlier this year, the National Advisory Committee on Immunization recommended RSV immunization for adults 75 years and older.
It also recommended adults 60 years and older get an RSV shot if they live in long-term care homes or other chronic care facilities. Moderna says its mRNA vaccine is the first RSV shot to come in a pre-filled syringe and says that will save time for health-care workers and reduce any errors in administering it.Canadian Press health coverage receives support through a partnership with the Canadian Medical Association. CP is solely responsible for this content.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Health Canada approves Moderna’s mRNA RSV vaccine, company saysAgency approves the vaccine to protect against respiratory syncytial virus in adults age 60 and older
Read more »
Health Canada approves Moderna's mRNA RSV vaccine, company saysTORONTO — Moderna says Health Canada has approved its mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older. The company says it expects the RSV vaccine — called mRESVIA — to be available in early 2025.
Read more »
Canada approves Moderna’s RSV vaccine, first of its kind for older adultsHealth Canada has approved the vaccine, mRESVIA, for the prevention of lower respiratory tract disease in older adults, the company said.
Read more »
Canada approves Moderna's RSV vaccine for adults aged 60 and olderModerna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years and older, making it the country's first authorized mRNA-based shot for the condition.
Read more »
Canada expands RSV protections to infantsFor the first time, Canada is offering an infant RSV vaccine as part of a public health program aimed at reducing hospitalizations caused by the highly contagious respiratory virus.
Read more »
Why researchers say Canada needs to prepare for the next health emergency nowA new report suggests future pandemics could be swifter and more severe than what was seen when COVID-19 began a worldwide spread.
Read more »